Stay updated on Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Results for NCT03222856 have been posted, including efficacy and safety outcomes. The study record now shows updated completion and enrollment dates.
    Difference
    0.4%
    Check dated 2025-11-02T00:52:47.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    42 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a prominent operating-status notice and links; v3.1.0 is removed.
    Difference
    2%
    Check dated 2025-10-04T12:33:13.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Update versioning from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-27T08:19:41.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Revision bumped to v3.0.2; 'Back to Top' link removed.
    Difference
    0.1%
    Check dated 2025-09-13T01:47:27.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-05T19:56:40.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of specific facility names and locations related to breast cancer treatment, while also removing previous references to certain locations and medical terms.
    Difference
    2%
    Check dated 2025-08-29T18:39:48.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial page.